Corticotrophin Adenoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2015-06-30
Clinical Trial Update: Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease [Phase 2]
A Phase 2 clinical trial evaluating gefitinib for USP8-mutated Cushing's disease, including patients with corticotrophin adenoma.